Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study

Elizabeth R Hauser1, Vincent Mooser, David C Crossman

  • 1Duke University Medical Center, Durham, NC 27710, USA.

Insights

Genetic factors strongly influence early-onset coronary artery disease (EOCAD). This study found significant sibling concordance for both traditional risk factors and lifestyle choices like smoking and sedentary behavior in EOCAD families.

Area of Science:

  • Cardiovascular Genetics
  • Human Genetics
  • Epidemiology

Background:

  • Coronary artery disease (CAD) is a major global health concern, with early-onset forms (EOCAD) exhibiting a strong genetic predisposition.
  • Identifying the specific genes contributing to EOCAD risk is crucial for understanding disease mechanisms and developing targeted interventions.

Purpose of the Study:

  • To conduct a genetic linkage study within the Genetics of Early Onset Cardiovascular Disease (GENECARD) study to identify chromosomal regions associated with EOCAD susceptibility.
  • To analyze a large cohort of families with at least one sibling pair affected by EOCAD.

Main Methods:

  • Utilized a comprehensive genetic strategy including genomic screening, fine mapping, candidate gene analysis, and family-based association studies.
  • Defined EOCAD based on acute coronary syndrome, revascularization, or positive functional imaging before age 50 (men) or 55 (women).
  • Included 920 families with affected sibling pairs across US and European study sites.

Main Results:

  • Exploratory analysis of 438 nuclear families (1168 members) revealed strong concordance for traditional cardiac risk factors among affected siblings, including diabetes, dyslipoproteinemia, obesity, and hypertension.
  • Notably, significant concordance was also observed for environmental/lifestyle factors such as smoking history, alcohol consumption, and sedentary lifestyle, suggesting complex gene-environment interactions in EOCAD.

Conclusions:

  • Findings highlight the significant genetic component in EOCAD, influencing both metabolic traits and lifestyle predispositions.
  • Results will inform population stratification for genome scan analysis and guide the selection of covariates for follow-up genetic studies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...